Article
Prostate cancer risk is not altered by TP53AIP1 germline mutations in a German case-control series.
PloS one - 1 Jan 2012
Luedeke Manuel, Coinac Irina, Linnert Carmen M, Bogdanova Natalia, Rinckleb Antje E, Schrader Mark, Vogel Walther, Hoegel Josef, Meyer Andreas, Dörk Thilo, Maier Christiane
Abstract excerpt
Prostate cancer susceptibility has previously been associated with truncating germline variants in the gene TP53AIP1 (tumor protein p53 regulated apoptosis inducing protein 1). For two apparently recurrent mutations (p.Q22fs and p.S32X) a remarkable OR of 5.1 was reported for prostate cancer risk. Since these findings have not been validated so far, we genotyped p.Q22fs and p.S32X in two German series with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
